CXCL13 and neoplasm: Importantly, a gene expression signature that indicates tumor reactivity in tumor-infiltrating lymphocytes (Supplementary Table 5), as identified by Lowery et al. [39], was enriched in the CD4+_CXCL13 and CD4+_MKI67 clusters (Supplementary Fig. 11H).